- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05886309
Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)
Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS): Pilot Study and First Experience in Testing Human Serum
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A clear interpretation of hyperferritinemia is difficult in many clinical situations. Crucial for the correct treatment of patients is the differentiation between reactively elevated ferritin and effective iron overload.The measurement methods that are routinely used provide quantitative results of the measurement of total ferritin molecules independent of their actual iron content.With a modified mass spectrometric method (CDMS), this should be possible.
In this study the investigators would like to apply this measurement technique for the first time with human serum as the investigators would like to test healthy blood donors with known normal, low or elevated ferritin levels.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Laura Infanti, PD Dr. med.
- Phone Number: +41 61 328 60 83
- Email: laura.infanti@usb.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- University Hospital Basel
-
Contact:
- Laura Infanti, PD Dr. med.
- Phone Number: +41 61 328 60 83
- Email: laura.infanti@usb.ch
-
Principal Investigator:
- Laura Infanti, PD Dr. med.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
The study cohort will include 20-25 experienced blood donors (not first-time donors) distributed among three groups according to SF values obtained from at least two previous measurements:
- low SF levels: < 20 ng/ml
- normal SF levels: 50-200 ng/ml (women) or 50-300 ng/ml (men)
- high SF levels: > 200 ng/ml (women) or > 300 ng/ml (men)
Description
Inclusion Criteria:
- age 18-75 years
- SF (serum ferritin) values known from a previous determination that must not be older than twelve months and not followed by a blood donation
- fulfillment of the eligibility criteria for blood donation
- negative serology for HBV (hepatitis B virus), HCV (hepatitis C virus), HIV (human immunodeficiency virus) as assessed in the context of a blood donation
Exclusion Criteria:
- acute illness
- chronic inflammatory disease
Since pregnancy is a contraindication for blood donation, no pregnant women will be included in the study.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of the mass of serum ferritin molecules (kDa)
Time Frame: one time assessment at baseline
|
The primary outcome is the mass of SF molecules measured using the CDMS method
|
one time assessment at baseline
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Laura Infanti, PD Dr. med., University Hospital, Basel, Switzerland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2023-00550; th22Infanti
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Serum Ferritin
-
Utah State UniversityBUILD Dairy; Glanbia NutritionalsRecruiting
-
Ain Shams UniversityUnknownBeta-thalassemia | Serum Ferritin | Iron Chelation TherapyEgypt
-
Shanghai 10th People's HospitalCompleted
-
University of DoualaCompleted
-
Tasso Inc.Recruiting
-
University of ConnecticutCompletedGut Microbiome | Serum CholesterolUnited States
-
AmgenCompletedElevated Serum Lipoprotein(a)Hong Kong
-
Nutrition Institute, SloveniaNational Institute of Public Health, Slovenia; Slovenian Research Agency; Higher...Enrolling by invitationVitamin D Serum LevelsSlovenia
-
University Hospital, LinkoepingUnknownMetabolic Rate | Plasma Glucose | Serum Insulin | Serum Triglycerides | Sense of SatietySweden
-
University of ChicagoRecruitingElevated Serum PSAUnited States
Clinical Trials on Collection of Blood samples
-
Centre Hospitalier Universitaire de NiceCompletedUrinary Tract InfectionsFrance
-
IgenomixRecruitingLeiomyoma, Uterine | Leiomyosarcoma UterusSpain
-
Centre Francois BaclesseLigue contre le cancer, France; Fondation de France; Centre National de la Recherche...Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Sun Yat-sen UniversityUnknownUveitis | Diabetic Retinopathy | Age-related Macular Degeneration | Polypoidal Choroidal Vasculopathy | Behçet Disease | VKH SyndromeChina
-
Assistance Publique - Hôpitaux de ParisFonds IMMUNOVCompleted
-
Centre Oscar LambretInstitut de Biologie de LilleTerminatedMelanoma | Kidney Neoplasms | Carcinoma, Hepatocellular | Colorectal NeoplasmsFrance
-
St. Louis UniversityCompletedInterstitial CystitisUnited States
-
Rennes University HospitalCompletedAcute Respiratory Distress Syndrome | SARS-CoV-2 CoronavirusFrance
-
Centre Jean PerrinRecruiting